Located at the heart of 900 acres commonly known as the South Texas Medical Center, UT Health San Antonio is the premier academic health institution of the seventh-largest city in the country. The interdisciplinary basic and clinical research across the institution's five schools (Medicine, Dentistry, Nursing, Health Professions, and Graduate) placed San Antonio among the top 3 Texas cities for funding from the National Institutes of Health in FY20.
15 members of the American Society of Clinical Investigation
1 member of the Sigma Theta Tau International Researcher Hall of Fame
10 members of the Association of American Physicians
11 fellows of the American Association for the Advancement of Science
17 fellows of the American Academy of Nursing
2 NIH Merit Awardees
2fellows of the National Academy of Inventors
46 UT System STARs, a program of the University of Texas System designed to recruit and retain faculty
The University of Texas Health Science Center at San Antonio (UT Health San Antonio) is among the top 50 on the Nature Index in the following categories, based on the articles published in the highest quality and most selective impact journals across the natural sciences.
Barshop Institute is the only aging-intensive research institute in the country to have the following four designations: two NIA-funded centers (Nathan Shock and Claude D. Pepper), a testing site of the NIA-sponsored Interventions Testing Program, and a U.S. Department of Veterans Affairs Geriatric Research, Education and Clinical Center.
Mays Cancer Center is the only NCI-designated cancer center in South Texas and now affiliated with the sister institution, UT MD Anderson Cancer Center in Houston. This affiliation fosters collaborations to advance breakthrough cancer research and streamlines protocols for multi-site clinical trials. In 2017, the center secured over $40 million in extramural grants, and more than 1,300 patients had the opportunity to participate in clinical trials.
The Institute for the Integration of Medicine & Science (IIMS) mission is to integrate clinical and translational research and career development across the university. Through a $5 million-dollar annual NIH Clinical and Translational Science Award (CTSA), the institute supports early-career investigators. In fiscal year 17 early-career investigator, Bianca Cerqueira (’16 Ph.D. Bioengineering), co-founded Novothelium, a startup focused on breast reconstruction.